Target intelligence / Profile preview

Outer membrane protein transporter (None)

Target
None
Molecular classification
Transporter, β-barrel membrane protein, Channel (porins), TonB-dependent transporter (subset), Omp85 superfamily (BamA and similar proteins)
01

Overview

Outer membrane protein transporters are integral β-barrel proteins embedded in the outer membrane of Gram-negative bacteria and select organelles, responsible for the transport of nutrients, metals, antibiotics, toxins, and cellular signals between the external environment and the periplasmic space. They are the first line of contact with the host and environment, often mediating cell adhesion, signaling, and virulence factor activity. These proteins include general porins (allowing passive flux), substrate-specific transporters such as TonB-dependent receptors (that require energy-coupling to transfer large or scarce nutrients), and assembly proteins like those of the Omp85 superfamily (responsible for membrane protein insertion and folding). Changes or mutations in these transporters are strongly associated with antibiotic resistance, adaptation to hostile environments, and pathogenesis, making them significant drug targets and potential biomarkers of infection and therapeutic outcome. This entry describes a protein class/family, not a specific protein, so for structured use or therapeutic targeting, it is essential to specify the individual protein (e.g., "BtuB", "OmpA", "BamA", "LptD").

Other names
OMP transporterouter membrane transporter proteinporin (depending on the subtype)β-barrel outer membrane protein
02

Mechanism of action

Drugs may block substrate transport, inhibit protein folding/insertion (e.g., BAM complex inhibitors), or disrupt channel function to prevent nutrient uptake and waste export

03

Biological functions

Nutrient uptake (e.g. iron, vitamin B12)Antibiotic influx/effluxWaste exportCell adhesionCell signalingVirulence factor
04

Disease associations

Infection (major role in Gram-negative bacterial pathogenicity)Antibiotic resistance (porins and efflux transporters)Other (can be associated with immune evasion and adaptation)
05

Safety considerations

Resistance due to altered expression or mutation of OMPs/transporterspossible off-target effects when targeting highly conserved protein familiesrapid adaptation leading to reduced drug efficacy
06

Interacting drugs

Various antibiotics (such as β-lactams, fluoroquinolones)

1 more in the full profile.

07

Biomarkers

Specific OMPs (e.g. OmpA, BamA, LptD) can serve as biomarkers for bacterial infectionantibiotic sensitivity

Beyond the preview

Go deeper on Outer membrane protein transporter (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Outer membrane protein transporter (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call